Allogene
ALLO

Allogene (ALLO) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
CitizensMaintainedMarket Outperform$6.00Aug 17, 2026
HC Wainwright & Co.MaintainedBuy$11.00 from $12.00Apr 16, 2026
JP MorganUpgradedUnderweight → NeutralApr 16, 2026
JefferiesMaintainedBuy$10.00 from $6.00Apr 15, 2026
HC Wainwright & Co.MaintainedBuy$12.00 from $8.00Apr 14, 2026
BairdMaintainedOutperform$9.00 from $7.00Apr 14, 2026
Argus ResearchMaintainedMarket Perform$3.85 from $1.60Apr 14, 2026
BernsteinMaintainedMarket Perform$3.85 from $1.60Apr 14, 2026
CitizensMaintainedMarket Outperform$8.00 from $5.00Apr 14, 2026
Piper SandlerMaintainedOverweight$8.00 from $7.00Mar 13, 2026
Canaccord GenuityMaintainedBuy$14.00Mar 13, 2026
CitizensUpgradedMarket Perform → Market Outperform$5.00Jan 9, 2026
UBSInitiated CoverageBuy$8.00Jan 7, 2026
JP MorganDowngradedNeutral → UnderweightOct 10, 2025
JP MorganDowngradedOverweight → NeutralAug 4, 2025
JMP SecuritiesMaintainedMarket PerformAug 4, 2025
CitigroupMaintainedBuy$4.00 from $8.00May 15, 2025
BairdMaintainedOutperform$9.00 from $12.00May 14, 2025
OppenheimerMaintainedOutperform$9.00 from $10.00May 14, 2025
RBC CapitalMaintainedOutperform$10.00May 14, 2025

Frequently asked questions

  • What is the latest analyst rating on ALLO?

    On Aug 17, 2026, Citizens maintained Allogene at Market Outperform with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.